Previous Image
Next Image

Key Personnel

 

Peter Hudson, FTSE, PhD, CSO Peter has a distinguished career spanning 30 years in genetic engineering and protein design with over 120 publications and 20 patents. Peter joined Avipep as CSO in 2008 after leading large multidisciplinary teams as a Chief Research Scientist and Program leader in CSIRO (1990-2008) and as Deputy CEO and Scientific Director of the CRC for Diagnostics (1995-2007). Peter has a PhD in molecular biology from Cambridge University. In 2005 he was elected fellow of ATSE and in 2001 he co-founded Evogenix Pty Ltd.

Clement Leong, PhD, Executive Chair. Clement has more than 18 years of biotech, pharma  and venture capital experience in Australia and the United States, with companies such as Merck Biopharma (formerly Schering-Plough BioPharma in Palo Alto, California), Entelos Inc. in Foster City, California and SciVentures Investments in Melbourne, Australia.  During this period he actively led multiple development programs and completed a series of financing and licensing transactions.  He was the founding chairman of Ascend and has led the Company’s clinical and preclinical programs. He has also been involved in the mezzanine funding of a number of ASX listed Australian biotech companies (e.g., Evogenix, ASX: EGX and Patrys Pty Ltd, ASX: PAB)and was the founding investor and an executive director in a number of private Australian biotech and medical device companies.   Clement earned his PhD from the Department of Medicine at the University of Western Australia and an MBA from the Australian Graduate School of Management (AGSM).

Board of Directors: Dr Clement Leong (Chair), Mr Ross Chessari, Professor Graham Mitchell.

Avipep also benefits from the input of a number of advisors who are leaders in their respective fields, including:

Prof Andrew Scott, MB, BS, ECFMG, FRACP, D.Med, Director of the PET Centre, Austin Hospital, Melbourne

A/Prof Greg Adams PhD; Fox Chase Cancer Center, Philadelphia, USA

Prof David Colcher, City of Hope National Medical Center, Duarte, CA, USA

Prof Rodney Hicks, MB BS (Hons), MD, FRACP, The Peter MacCallum Cancer Centre, Melbourne.